Cannabis: Q3 results could trigger further share price weakness
CannabisQ3 results could trigger further share price weakness
Harmonizing valuations downward
Concern no 1: Persistent losses at larger operators
Concern no 2: Weak Q3 CY19 due to inventory build-up
Concern no 3: Vaping health issues to impact US MSO and potentially delay Canadian introduction
Aurora Cannabis is engaged in the acquisition, exploration and development of resource properties, primarily in Canada.
iAnthus Capital Holdings is principally engaged in the delivery of solutions for financing, developing and managing state-licensed cannabis cultivators and dispensaries throughout the United States. Through its subsidiaies, Co. provides financing and related management and advisory services to state-licensed operators engaged in the cultivation, manufacturing and dispensing of cannabis throughout the United States, where medical and/or adult use cannabis is legal. Co. operates through the following two geographical segments: Canada and the United States of America.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.